Rivastigmine: An open-label observational study of behavioral symptoms identified as most troubling by caregivers of patients with Alzheimer's disease

Mary Lu Anne Lilly, Martin R. Farlow

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Rivastigmine: An open-label observational study of behavioral symptoms identified as most troubling by caregivers of patients with Alzheimer's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences